Icagen offers industry-leading scientific expertise and comprehensive services for ion channel and transporter drug discovery and development.

Icagen offers pharmaceutical and biotechnology companies industry-leading scientific e...
See More xpertise and comprehensive services for ion channel and transporter drug discovery and development.

Icagen has an extensive collection of cell lines and assay technologies for ion channel and transporter research including the company’s proprietary, label-free XRpro® platform. XRpro® technology, based on X-ray fluorescence, is a novel method that enables high throughput assessment of ion channels and transporters, including challenging systems of high therapeutic interest.

With over 20 years of leadership in the ion channel field, Icagen presents an extensive track record of success in advancing molecules from drug discovery to clinical development across multiple therapeutic areas and ion channel classes.

Icagen was re-launched by XRpro Sciences in June, 2015 through an acquisition of Pfizer’s team and technology.